Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
-
Allogene Therapeutics Announces Participation in Three Upcoming Investor Conferences
-
Allogene Therapeutics Announces Participation in Seven Upcoming Investor Conferences
-
Allogene Therapeutics Announces Participation in Seven Upcoming Investor Conferences
-
Allogene Therapeutics Announces Participation in Two Upcoming Virtual Investor Conferences
-
Allogene Therapeutics Announces Participation in Two Upcoming Virtual Investor Conferences
-
Allogene Therapeutics (ALLO) Prices 11.7M Share Common Offering at $47/Sh
-
Allogene Therapeutics Announces Pricing of Public Offering of Common Stock
-
Allogene Therapeutics Announces Pricing of Public Offering of Common Stock
-
Allogene Therapeutics Announces Participation in Two Upcoming Virtual Investor Conferences
-
Allogene Therapeutics Announces Participation in Two Upcoming Virtual Investor Conferences
-
Canaccord Genuity Starts Allogene (ALLO) at Buy
